As discussed in this review, the pharmacological profile of classic calcium channel blockers in psychiatric disorders has still to be ascertained ( Casamassima et al., 2010); instead calcium channel modulators targeting the α2δ subunits are showing positive results ( Valente et al., 2012). This evidence concerns the gene ATXN2L and psychiatric disorder.